Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas
- PMID: 16651410
- PMCID: PMC5407689
- DOI: 10.1158/0008-5472.CAN-05-4196
Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas
Abstract
Microarray gene expression profiling is a powerful tool for generating molecular cancer classifications. However, elucidating biological insights from these large data sets has been challenging. Previously, we identified a gene expression-based classification of primary uveal melanomas that accurately predicts metastatic death. Class 1 tumors have a low risk and class 2 tumors a high risk for metastatic death. Here, we used genes that discriminate these tumor classes to identify biological correlates of the aggressive class 2 signature. A search for Gene Ontology categories enriched in our class-discriminating gene list revealed a global down-regulation of neural crest and melanocyte-specific genes and an up-regulation of epithelial genes in class 2 tumors. Correspondingly, class 2 tumors exhibited epithelial features, such as polygonal cell morphology, up-regulation of the epithelial adhesion molecule E-cadherin, colocalization of E-cadherin and beta-catenin to the plasma membrane, and formation of cell-cell adhesions and acinar structures. One of our top class-discriminating genes was the helix-loop-helix inhibitor ID2, which was strongly down-regulated in class 2 tumors. The class 2 phenotype could be recapitulated by eliminating Id2 in cultured class 1 human uveal melanoma cells and in a mouse ocular melanoma model. Id2 seemed to suppress the epithelial-like class 2 phenotype by inhibiting an activator of the E-cadherin promoter. Consequently, Id2 loss triggered up-regulation of E-cadherin, which in turn promoted anchorage-independent cell growth, a likely antecedent to metastasis. These findings reveal new roles for Id2 and E-cadherin in uveal melanoma progression, and they identify potential targets for therapeutic intervention.
Figures





Similar articles
-
Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis.Melanoma Res. 2008 Jun;18(3):191-200. doi: 10.1097/CMR.0b013e3283005270. Melanoma Res. 2008. PMID: 18477893
-
Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2).Graefes Arch Clin Exp Ophthalmol. 2009 Mar;247(3):411-9. doi: 10.1007/s00417-008-1008-z. Epub 2008 Nov 29. Graefes Arch Clin Exp Ophthalmol. 2009. PMID: 19043732
-
Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death.Cancer Res. 2004 Oct 15;64(20):7205-9. doi: 10.1158/0008-5472.CAN-04-1750. Cancer Res. 2004. PMID: 15492234 Free PMC article.
-
Genetic determinants of uveal melanoma.Dev Ophthalmol. 2012;49:150-165. doi: 10.1159/000328270. Epub 2011 Oct 21. Dev Ophthalmol. 2012. PMID: 22042019 Review.
-
Uveal melanoma: Towards a molecular understanding.Prog Retin Eye Res. 2020 Mar;75:100800. doi: 10.1016/j.preteyeres.2019.100800. Epub 2019 Sep 26. Prog Retin Eye Res. 2020. PMID: 31563544 Review.
Cited by
-
Recent advances in understanding the role of HES6 in cancers.Theranostics. 2022 May 20;12(9):4374-4385. doi: 10.7150/thno.72966. eCollection 2022. Theranostics. 2022. PMID: 35673577 Free PMC article. Review.
-
Expression analysis of genes and pathways associated with liver metastases of the uveal melanoma.BMC Med Genet. 2014 Mar 5;15:29. doi: 10.1186/1471-2350-15-29. BMC Med Genet. 2014. PMID: 24597767 Free PMC article.
-
ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm.Mol Vis. 2008;14:1912-28. Epub 2008 Oct 29. Mol Vis. 2008. PMID: 18958307 Free PMC article.
-
The biology and management of uveal melanoma.Curr Oncol Rep. 2008 Sep;10(5):431-8. doi: 10.1007/s11912-008-0066-z. Curr Oncol Rep. 2008. PMID: 18706273 Review.
-
Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.PLoS One. 2012;7(1):e29989. doi: 10.1371/journal.pone.0029989. Epub 2012 Jan 13. PLoS One. 2012. PMID: 22267972 Free PMC article.
References
-
- Harbour JW. Clinical overview of uveal melanoma: introduction to tumors of the eye. In: Albert DM, Polans A, editors. Ocular oncology. New York: Marcel Dekker; 2003. pp. 1–18.
-
- Eskelin S, Pyrhonen S, Summanen P, Hahka-Kemppinen M, Kivela T. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology. 2000;107:1443–9. - PubMed
-
- Callender GR. Malignant melanotic tumors of the eye: a study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol. 1931;36:131–42.
-
- Folberg R, Pe'er J, Gruman LM, et al. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol. 1992;23:1298–305. - PubMed
-
- Gamel JW, McLean IW. Quantitative analysis of the Callender classification of uveal melanoma cells. Arch Ophthalmol. 1977;95:686–91. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical